Bankrupt 23andMe finally settles with 2023 data breach victims. The settlement of $46.75 million was approved by the US Bankruptcy Court for the Eastern District of Missouri. It will be paid first to Kroll Restructuring within five business days from Tuesday 7 July. It will then be distributed among those who filed with Kroll as affected by the breach of their genetic and personal information. The breach occurred between 1 May and 1 October 2023. 

The benefits to those affected and filing a claim are:

• Up to $10,000 for Extraordinary Claims;
• Up to $165 for Health Information Claims;
• An estimated $100 for Statutory Cash Claims; and
• 5 years of Privacy & Medical Shield + Genetic Monitoring

This is a second round settlement. The first settlement dates back to before the bankruptcy [TTA 17 Sept 2024] and was for $30 million. 23andMe filed for bankruptcy on 24 March 2025 after multiple buyout offers by Anne Wojcicki and others. Wojcicki eventually bought the company through her TTAM Research Institute in July 2025, then converted the holding company name to Chrome Holding Co. and ChromeCo, Inc. d/b/a 23andMe.

What exactly Wojcicki intends to do with what’s left of 23andMe after emerging from bankruptcy is anyone’s guess.

The estimated number of people affected by the breach was 6.9 million. $14.29 million has already been distributed, possibly through the earlier settlement agreement. At the time, 23andMe said that $25 million was covered by their cyber insurance. Kroll authorized website, BBC News, Fox 5 Washington

The Neuralink brain computer interface (BCI) implant hits #26 in clinical trial, has first Canadian ALS patient. Lee Marten is a sergeant with the Vancouver police department who has had ALS since 2022. His mobility is limited to his hands operating his electric wheelchair. With the Neuralink N1 BCI implant, he can move a computer cursor by thought. Sgt. Marten is part of a clinical trial at University Health Network’s (UHN) Toronto Western Hospital. He is the 26th patient in a series of US and Canadian clinical trials among spinal injury quadriplegic and the first Canadian with ALS.  Mobihealthnews, CBC News

Resmed sells its MatrixCare software business for $490 million in cash. The buyer is private equity firm Frazier Healthcare Partners. Going forward, ResMed will use the cash to expand and concentrate on its core sleep health, respiratory, and connected home-based healthcare. The press release anticipates the closing as Q1 2027. (Resmed’s FY closes in September so this is end of 2026.) There is no information in the release on management or headquarters transitions. The Reuters report ​said that “transition ⁠services agreements with Frazier are expected to help ensure continuity across systems and operations and ​largely offset stranded costs in the first year ​after closing”.

The haircut was substantial. Resmed purchased MatrixCare in 2019 for $750 million for its EHR and software products to expand into a specialized area of post-acute care–an extremely tough one. They currently serve 15,000 providers across ​skilled nursing, senior living, long-term care, home health and hospice ​markets under the MatrixCare, Healthcare First, and Citus brands. However, its growth lagged company averages, according to KeyBanc Capital Markets’ note to investors. The sale at a clear loss has all signs of ‘throwing in the towel’ on a difficult to market and lower margin sector.

ResMed is retaining Brightree in the US and MEDIFOX DAN in Germany. Brightree provides business management and clinical solutions for post-acute care providers. MEDIFOX DAN provides management software for the German healthcare and social care sectors. Their individual value and profitability is unknown.

MatrixCare in the preliminary filing generated about $220 million in revenue and about $55 million in adjusted operating ‌profit ⁠in fiscal year 2026. Healthcare Dive

And to wind up on a lighter marketing note, Teladoc is now the preferred telehealth provider of the National Basketball Players Association (NBPA). The NBPA is the union for the professional players in the National Basketball Association (NBA). Teladoc will provide virtual care services for active and retired NBA players and their families. They will have access to Teladoc’s multidisciplinary virtual services, including primary care, 24/7 urgent care and preventive health screenings. NBPA and Teladoc Health will also host a preventive health screening for NBPA members at Summer League in Las Vegas. NBPA release, Mobihealthnews